Mind Medicine (MindMed) I... (MNMD)
NASDAQ: MNMD
· Real-Time Price · USD
11.91
-0.75 (-5.92%)
At close: Oct 16, 2025, 3:59 PM
11.88
-0.25%
After-hours: Oct 16, 2025, 07:52 PM EDT
-5.92% (1D)
| Bid | 11.87 |
| Market Cap | 906.21M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -114.52M |
| EPS (ttm) | -1.34 |
| PE Ratio (ttm) | -8.89 |
| Forward PE | -6.93 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 12.29 |
| Volume | 1,661,181 |
| Avg. Volume (20D) | 1,458,959 |
| Open | 12.74 |
| Previous Close | 12.66 |
| Day's Range | 11.90 - 12.84 |
| 52-Week Range | 4.70 - 13.09 |
| Beta | 3.31 |
| Ex-Dividend Date | n/a |
About MNMD
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MNMD
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MNMD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+12.05%
Shares of psychedelic companies are trading higher...
Unlock content with
Pro Subscription
3 months ago
+7.52%
Shares of psychedelic companies are trading higher following a report suggesting that the US Department of Health and Human Services Secretary Robert F. Kennedy Jr said the agency is committed to expanding research on the benefits of psychedelic therapy and is working with the FDA head to provide legal access for military veterans within 12 months.
